Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

继54亿美元并购而来的镰刀型细胞病（SCD）药物Oxbryta从全球市场撤回，5.25亿美元引进的口服RSV疗法打水漂后，有些“水逆”的辉瑞迎来潜在转折性一刻：华尔街知名的激进投资者/维权投资基金Starboard ...

据知情人士向媒体透露，激进投资者Starboard认为辉瑞现任首席执行官Albert Bourla的领导下，公司已经偏离了其传统的成本控制和对新药投资的严谨结构，目前已经接触了辉瑞前首席执行官Ian Read和前首席财务官Frank D’Amelio ...

Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist ...

辉瑞CEO Albert Bourla最近有点烦。 不仅是因为公司业绩持续下滑，还有近日著名的激进投资者Starboard Value盯上了辉瑞，CEO或面临“下台”风险。 激进投资者（Activist ...

CEO Albert Bourla is expected to meet with activist investor Starboard Value next week after the activist accumulated a $1 ...

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

纽约 - 投资公司星桥资本有限合伙公司(Starboard Value LP)作为制药巨头辉瑞制药公司(NYSE: ...

Here are some of the major companies whose stocks moved on the week’s news.